EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss

BenzingaDec 20 11:49 ET

EXCLUSIVE: Novo Nordisk Faces Political Heat Over Weight-Loss Drug Prices Ahead Of Elections, Yet 'The Real Issue Is With The Middlemen'

BenzingaSep 25 09:35 ET

The GLP-1 Makers to Add to Your Portfolio: Tema ETFs CEO

Yahoo FinanceAug 8 17:06 ET

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'

BenzingaJul 18 16:59 ET

EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO

BenzingaJul 7 09:39 ET

This Weight-loss ETF Has Performed Well in Its First Five Months. How Does It Compare With Cheaper Alternatives?

MarketWatchApr 10 09:27 ET